Welcome to our dedicated page for 180 Life Sciences SEC filings (Ticker: ATNFW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
180 Life Sciences Corp. filings document the issuer’s securities, capital structure, governance actions and corporate-status changes, including its completed name change to ETHZilla Corporation. Recent Form 8-K reports address Nasdaq-listed common stock and warrants, ticker changes to ETHZ and ETHZW, warrant exercises, unregistered equity issuances, private placements, convertible notes and Regulation FD disclosures.
The filing record also includes material definitive agreements, amendments to prior event reports, shareholder-rights and governance matters, and disclosures related to the company’s ETH accumulation strategy. Earlier public-company records provide context for the issuer’s history as a clinical-stage biotechnology company focused on inflammatory diseases, fibrosis and pain.